Polymorphisms and expression of IL-32: impact on genetic susceptibility and clinical outcome of lung cancer

Biomarkers. 2017 Mar;22(2):165-170. doi: 10.1080/1354750X.2016.1252956. Epub 2016 Nov 8.

Abstract

Context: Polymorphisms of IL-32 related closely to tumoregenesis.

Materials and methods: Two IL-32 polymorphisms (rs12934561 and rs28372698) and mRNA expression were conducted by SNP genotype assay and real-time PCR in 423 lung cancer patients and 437 controls.

Results: T allele of rs28372698 associated significantly with poor prognosis in moderate and well-differentiated lung cancer patients. TT genotype of rs12934561 related closely to poor survival status in squamous carcinoma. IL-32 mRNA expression decreased in lung cancer.

Discussion and conclusion: Our study indicates the importance of IL-32 polymorphism and mRNA expression in susceptibility and influence of survival status in lung cancer.

Keywords: IL-32; lung cancer; prognosis; single-nucleotide polymorphism; survival status.

MeSH terms

  • Carcinoma, Squamous Cell / genetics
  • Carcinoma, Squamous Cell / mortality
  • Case-Control Studies
  • Gene Expression
  • Genetic Predisposition to Disease
  • Genotype
  • Humans
  • Interleukins / genetics*
  • Lung Neoplasms / genetics*
  • Lung Neoplasms / mortality
  • Polymorphism, Single Nucleotide*
  • Prognosis
  • RNA, Messenger / analysis

Substances

  • IL32 protein, human
  • Interleukins
  • RNA, Messenger